F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats
The Food and Drug Administration for the first time has authorized a genetic testing company to offer screenings for three breast cancer mutations common in Ashkenazi Jews, giving consumers the ability to initiate testing at home and see results without talking to a doctor or counselor.
